New AMA data show limited insurer competition in commercial and Medicare Advantage markets, which can cut into physicians’ negotiating power and payment.
With projected shortfalls of 86,000 to more than 187,000 physicians within a decade, burnout, an aging workforce and capped residency slots are squeezing supply. Here are the training, payment, prior authorization and workplace changes that could help close the gap.
Starting Jan. 1, Medicare will pay 20% less for the lower-valued service when an office visit billed with modifier 25 falls on the same day as a zero-day global procedure. One claims report priced at local 2027 rates shows independent practices their exposure, and three documentation habits protect the visits that still qualify for full payment.
The Commerce Department’s Section 232 investigation could bring new tariffs on imported medical devices and supplies. Targeted reserves, procurement preferences and a faster FDA pathway for switching to U.S. suppliers would do more to bring device manufacturing home.
Higher Part D deductibles, rising Medigap and Part B premiums and the end of $0-premium drug plans may lead patients to skip refills and visits early in 2027. Here’s who is most exposed, why lower utilization could mask 2028 costs and what to do before Dec. 7 and in January.